(Q43510336)

English

Early post-treatment pseudo-progression amongst glioblastoma multiforme patients treated with radiotherapy and temozolomide: a retrospective analysis

scientific article published in December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Early post-treatment pseudo-progression amongst glioblastoma multiforme patients treated with radiotherapy and temozolomide: a retrospective analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Ashray Gunjur

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Eddie Lau

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Yamna Taouk

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Gail Ryan

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Journal of Medical Imaging and Radiation Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

603-610

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Response criteria for glioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Evaluation of malignant glioma patients during the postirradiation period

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1754-9485.2011.02319.X

21 January 2018

Identifiers

10.1111/J.1754-9485.2011.02319.X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43510336&oldid=1990289225"